Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 18.6% in the morning session after Jefferies raised its price target on the stock amid growing optimism over a potential shift in U.S. federal cannabis policy.
Shares of Tilray Brands are trading sharply higher Monday morning. The stock is being bolstered by a positive note from Jefferies and growing optimism around significant U.S. cannabis reform this year.
Tilray's stock rally is fueled by market anticipation of a U.S. cannabis rescheduling decision, a key catalyst for the entire cannabis sector's future.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Delaware’s first weekend of legal recreational cannabis sales wrapped up with better-than-expected results, marking an important step forward for the state’s new adult-use cannabis program. Sales officially kicked off on August 1, drawing in both seasoned medical patients and first-time recreational buyers.
Delaware’s first weekend of legal recreational cannabis sales wrapped up with better-than-expected results, marking an important step forward for the state’s new adult-use cannabis program. Sales officially kicked off on August 1, drawing in both seasoned medical patients and first-time recreational buyers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at beverages, alcohol, and tobacco stocks, starting with Tilray (NASDAQ:TLRY).
A number of stocks fell in the afternoon session after markets pulled back amid hotter-than-expected inflation data. The main concern for investors was the July Producer Price Index (PPI), a measure of wholesale inflation. The higher-than-expected reading suggests that companies could face squeezed profit margins due to rising costs. This also reduces the likelihood of the Federal Reserve cutting interest rates, which could further dampen economic activity. Compounding these inflation fears are multiple reports signaling a weakening consumer.
Tilray said it was evaluating several options, including, but not limited to, a stockholder-approved reverse stock split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.
